Themis Medicare LimitedNSE: THEMISMED

Press Release Mar 03 2022

· Issued by Themis Medicare Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-mar-03-2022-12

Themis Medicare Limited has informed the Exchange about press release dated 03-Mar-2022 titled Indian regulator approves VIRALEX for the treatment of mild to moderate COVID-19 in India

View Attachment

6ix hasn’t read this filing yet.

Themis Medicare Limited on 6ix

Earlier from Themis Medicare

Later from Themis Medicare

All Themis Medicare news releases